Building on our previous report on the TGM2 in other tumours and on the effects of retinoic acid which involves GATA3 14, we decided to investigate the modulation of the TGM2 response because GATA3 interacts both with the promoter and additional binding/pausing sites within the intron 10. This evidence concerns the gene GATA3 and neoplasm.